Skip to content
Digital Insights Hub

Zimbabwe Turns Down ‘Lopsided’ American Health Aid Agreement Due to Data Fears

Health aid illustration
The proposed US funding would have supported initiatives for HIV/Aids treatment and prevention, tuberculosis, and malaria.

The nation of Zimbabwe has turned down a substantial US health deal valued at $367m (£272m) spanning five years over Washington's demand for sensitive biological samples.

The decision became public following a official document from December was disclosed, indicating that President Emmerson Mnangagwa felt the arrangement was "skewed".

A government spokesperson later clarified that the US was requesting health data for research and profit but was unwilling to guarantee the resulting advantages from any future medical innovations.

"We will now turn to the challenging and unfortunate process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the United States had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has appealed for more negotiations to reach a deal suitable to all parties so the nation's vital HIV programme can continue.

Broader Background

This rejection follows a comparable situation in neighbouring Kenya, where a court halted a similar deal with the US following legal challenges were filed about the safety of Kenyans' health data.

Since resuming the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

USAID had managed aid for the American government, but Trump claimed its spending was "wasteful" and his administration was seeking direct bilateral agreements to boost openness and accountability.

As per statements, 16 nations in Africa have so far signed similar agreements, constituting over $18.3bn in new funding.

Details of the Declined Agreement

This assistance for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this collaboration might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," Tremont added.

However, government spokesperson Nick Mangwana said the arrangement was "unequal".

"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, with no equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.

"In essence, our nation would provide the raw materials for scientific discovery with no certainty that the end products would be available to our population if a future disease outbreak arise."

National Interest and International Frameworks

Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were undermining structures previously established through the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage potential pandemics.

"This mechanism is intended to ensure that when a nation contributes its data, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the funds to develop them."

These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We encourage further dialogue with our US partners on how future co-operation could be designed in a manner that honours the independence and interests of both nations."

Medical Community Reaction

A leading public health body said it recognised the government's concerns, but urged that negotiations need to persist since much of the country's Aids initiatives were funded by foreign aid.

"Where technical issues exist, such as those involving information security or implementation frameworks, these can often be resolved via detailed discussion and mutually agreed protections," it added.

The situation underscores the complex debate between accepting crucial foreign assistance and safeguarding a country's data in an increasingly interconnected world.

About the author

Kelly Young

Tech enthusiast and writer passionate about exploring how digital innovations shape everyday life and future possibilities.

Digital Insights Hub

Type to search articles.